{
  "identifier": "cdd0849d-2c5a-492e-a485-3fee19beca5e",
  "version": "1.0.0",
  "revisions": [],
  "issued": "2024-01-01T00:00:00.000Z",
  "modified": "2024-01-01T00:00:00.000Z",
  "summary": {
    "title": "Metastatic Melanoma Immunotherapy Response Registry",
    "abstract": "Real-world data on 1200 patients with metastatic melanoma treated with checkpoint inhibitors (anti-PD1/CTLA4). Includes progression-free survival and immune-related adverse events.",
    "dataCustodian": {
      "identifier": "https://ror.org/custodian-4",
      "name": "Melanoma Focus Registry",
      "contactPoint": "access@custodian-4.org"
    },
    "funders": "CRUK\nNIHR",
    "populationSize": 4206,
    "keywords": [
      "Metastatic",
      "Melanoma",
      "Immunotherapy",
      "Response",
      "Registry"
    ],
    "doiName": "10.1000/data.4",
    "contactPoint": "access@custodian-4.org"
  },
  "documentation": {
    "description": "Real-world data on 1200 patients with metastatic melanoma treated with checkpoint inhibitors (anti-PD1/CTLA4). Includes progression-free survival and immune-related adverse events. This is a dummy description generated for testing purposes.",
    "inPipeline": "Available"
  },
  "coverage": {
    "spatial": "United Kingdom",
    "followUp": "1 - 10 Years"
  },
  "provenance": {
    "origin": {
      "purpose": [
        "Study"
      ],
      "datasetType": [
        "Health and disease"
      ]
    },
    "temporal": {
      "publishingFrequency": "Annual",
      "startDate": "2020-01-01",
      "timeLag": "1-2 months"
    }
  },
  "accessibility": {
    "usage": {
      "dataUseLimitation": [
        "General research use"
      ]
    },
    "access": {
      "accessRights": "Open access upon request.",
      "jurisdiction": [
        "GB-ENG"
      ]
    },
    "formatAndStandards": {
      "vocabularyEncodingScheme": [
        "ICD10"
      ],
      "conformsTo": [
        "OMOP"
      ],
      "language": [
        "en"
      ],
      "format": [
        "text/csv"
      ]
    }
  },
  "observations": [
    {
      "observedNode": "Persons",
      "measuredValue": 3523,
      "observationDate": "2023-12-31",
      "measuredProperty": "Count"
    }
  ],
  "demographicFrequency": {
    "age": [
      {
        "bin": "50-54 years",
        "count": 10
      },
      {
        "bin": "55-59 years",
        "count": 20
      }
    ],
    "ethnicity": [
      {
        "bin": "White - British",
        "count": 25
      },
      {
        "bin": "Not stated",
        "count": 5
      }
    ]
  },
  "datasetFilters": [
    {
      "id": "0_0_0_8",
      "label": "C49 Connective, subcutaneous and other soft tissues",
      "category": "icdOTopography",
      "primaryGroup": "cancer-type",
      "description": ""
    },
    {
      "id": "0_0_1_15",
      "label": "872-879 Nevi and melanomas",
      "category": "icdOHistology",
      "primaryGroup": "cancer-type",
      "description": ""
    },
    {
      "id": "0_2_3_6",
      "label": "Clinical Trial",
      "category": "Patient study",
      "primaryGroup": "data-type",
      "description": ""
    },
    {
      "id": "0_2_3_5",
      "label": "Treatments",
      "category": "Patient study",
      "primaryGroup": "data-type",
      "description": ""
    },
    {
      "id": "0_1_4",
      "label": "Open to applicants",
      "category": "accessType",
      "primaryGroup": "access-type",
      "description": ""
    },
    {
      "id": "0_0_2_56",
      "label": "Melanoma skin cancer",
      "category": "crukTerms",
      "primaryGroup": "cancer-type",
      "description": ""
    },
    {
      "id": "0_0_4_29",
      "label": "SKCM (Skin Cutaneous Melanoma)",
      "category": "cancerTypes",
      "primaryGroup": "cancer-type",
      "description": ""
    }
  ],
  "project": {
    "projectName": "MEL-REG: A National Registry for Immunotherapy Response in Metastatic Melanoma",
    "leadResearcher": "Dr L.J. Chen",
    "leadResearchInstitute": "Medical Research Council Laboratory of Molecular Biology (LMB)",
    "grantNumbers": "JLSJJLBAMA_413528364",
    "projectStartDate": "2023-01-19",
    "projectEndDate": "2028-01-19",
    "projectScope": "Longitudinal clinical registry data for metastatic melanoma patients, including immunotherapy response, survival, and adverse events."
  }
}